BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, April 28, 2024
See today's BioWorld
Home
» In the clinic for April 4, 2022
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
In the clinic for April 4, 2022
April 4, 2022
No Comments
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aadi, Acelrx, Alligator, Altimmune, Anebulo, Arca, Athira, Biohaven, Cerevance, Cidara, Develco, Eli Lilly, Evofem, Finch, HMNC, Inozyme, Janssen, Longeveron, Merck, Ocugen, Pharming, Ridgeback, Sage, Sirnaomics, Wave Life, Zhimeng, Zhongze.
BioWorld
Briefs
In the clinic
Coronavirus